Format:
1 Online-Ressource (87 Seiten)
,
Illustrationen
ISBN:
9781009336123
Series Statement:
Cambridge elements
Content:
The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This text highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management
Note:
Also issued in print: 2023. - Includes bibliographical references
Additional Edition:
Erscheint auch als Druck-Ausgabe ISBN 978-1-00-933613-0
Language:
English
Subjects:
Medicine
DOI:
10.1017/9781009336123
URL:
Volltext
(URL des Erstveröffentlichers)
